
CANONSBURG, Pa., June 15 (UPI) -- Mylan Laboratories Inc., a Pennsylvania-based generic drugmaker, plans to buy back nearly a quarter of its shares and double its dividend.
The moves come as takeover artist Carl Icahn, Mylan's biggest shareholder, has been trying to replace the company's board and boost his own stake in the company, the Pittsburgh Post-Gazette reported.
"We are pleased that Mylan has finally announced actions attempting to enhance shareholder value," Icahn said Wednesday.
"However, it is a sad commentary that Mylan needed the strong prodding of its largest shareholder to take the actions that were announced this morning. Additionally, it should be noted that Mylan's partial tender offer is for the most part at a price below our acquisition proposal."
Icahn has been offering $20 per share for Mylan, while the company is paying about $20.50 for its own shares, the newspaper said.
|
|
|
|
|
|
| Additional Business News Stories | |
ABUJA, Nigeria, May 23 (UPI) --
The Nigerian government has "aggressive" investment programs in place to provide a major boost to the oil and natural gas sector, a minister said.
|
FORT WAYNE, Ind., May 23 (UPI) --
Self-encrypting drives to protect data on mobile platforms such as laptops are to be developed for the U.S. Air Force by ITT Exelis.
|
The housing inventory rose slightly in April, which is unusual in the middle of the spring sales season. The uptick may be the result of rising seller confidence and it should ease concerns that the super tight inventory levels of the last six months...
|
What if Europe turned out to be the new Japan?
|
| Stories | Photos | People | Comments |
View Caption